Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Price to Earnings (P/E)
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Medtronic PLC, P/E, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Medtronic PLC Annual Report.


The financial trajectory from 2005 to 2026 exhibits significant volatility in valuation multiples and share price, characterized by distinct phases of contraction, expansion, and subsequent normalization.

Share Price Dynamics
The share price experienced a period of relative stability and moderate decline between 2005 and 2012, reaching a cyclical low of 33.37 in 2009. A sustained growth phase emerged after 2013, with the price ascending to a peak of 124.93 in 2021. Following this peak, a correction occurred, with the price stabilizing between 79.34 and 88.67 during the 2022 to 2026 period.
Earnings per Share (EPS) Performance
EPS demonstrated a general upward trend from 1.49 in 2005 to 3.53 in 2012. A period of volatility followed, marked by a significant decline to 1.89 in 2015. Earnings subsequently recovered and fluctuated between 2.30 and 3.79, ending the period at 3.75 in 2026, which indicates a long-term increase in fundamental profitability.
Price-to-Earnings (P/E) Ratio Trends
The P/E ratio underwent three distinct phases. From 2005 to 2012, a contraction is observed, with the ratio falling from 35.12 to a low of 10.57. A period of valuation expansion followed between 2013 and 2021, reaching a maximum of 46.56. The final phase, from 2022 to 2026, shows a steady regression toward a more moderate valuation, concluding at 21.15.

A notable divergence occurs in 2015, where a sharp decrease in EPS to 1.89 coincided with a P/E spike to 40.56, suggesting that market sentiment remained bullish despite a temporary drop in earnings. Similarly, the valuation peak in 2021 aligns with the maximum share price, indicating that the price increase significantly outpaced earnings growth during that interval. The most recent data suggests a convergence where the P/E ratio is stabilizing as earnings remain relatively strong.



Comparison to Competitors

Medtronic PLC, P/E, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).



Comparison to Sector (Health Care Equipment & Services)



Comparison to Industry (Health Care)